The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Michael P. Boyle, MD, senior vice president of therapeutics development, and Tony Durmowicz, MD, vice president of clinical development, will discuss emerging therapies as well as ongoing and upcoming clinical trials. Special attention will be paid to updates regarding next-generation CFTR modulators.
